Dylan is the Founder & CEO of Mindbloom, an NYC-based mental health and wellbeing startup helping people expand their human potential with clinician-prescribed, guided psychedelic medicine experiences. There, he is partnering with clinicians, technologists, researchers, and patients to increase access to science-backed treatments, starting by reducing the cost of ketamine therapy for depression and anxiety by over 65%.Dylan is a 10-year psychedelic medicine patient and 3-time tech entrepreneur with both $100M+ in funding and an exit in his prior startups, which were focused on increasing access to justice and democracy. Dylan graduated from The Wharton School at The University of Pennsylvania.____________________SHOW NOTESFull Show Notes, Transcript and YouTube Clips can be found at www.mindthings.co/dylan-beynon/____________________LINKShttps://www.mindbloom.co/____________________MIND THINGSFollow us on Twitter: @mindthingscoSubscribe to our newsletterFollow us on YouTube